The effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients with refractory factors in the real world: a comprehensive analysis of a prospective multicenter study

the KTK49 Liver Study Group, Akito Nozaki, Masanori Atsukawa, Chisa Kondo, Hidenori Toyoda, Makoto Chuma, Makoto Nakamuta, Haruki Uojima, Koichi Takaguchi, Hiroki Ikeda, Tsunamasa Watanabe, Shintaro Ogawa, Norio Itokawa, Taeang Arai, Atsushi Hiraoka, Toru Asano, Shinichi Fujioka, Tadashi Ikegami, Toshihide Shima, Chikara Ogawa, Takehiro Akahane, Noritomo Shimada, Shinya Fukunishi, Hiroshi Abe, Akihito Tsubota, Takuya Genda, Hironao Okubo, Shigeru Mikami, Asahiro Morishita, Akio Moriya, Joji Tani, Yoshihiko Tachi, Naoki Hotta, Toru Ishikawa, Takeshi Okanoue, Yasuhito Tanaka, Takashi Kumada, Katsuhiko Iwakiri, Shin Maeda